Atlas Trials

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes

Clinical trial NCT01910844 · TERMINATED

Trial details

NCT number
NCT01910844
Sponsor
Centre Jean Perrin
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-07-01
Primary completion
2016-09-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.